Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients
Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.